NEWARK, Delaware – CSols, Inc. the premier Laboratory Informatics consultancy, announced the successful completion of the enhancement and extension of GenoLogics Clarity Lab Information Management System (LIMS) for Adaptive Biotechnologies, the leader in high-throughput immunosequencing. To make use of several new features, and to further automate the processing and management of its assays, Adaptive Biotechnologies decided to upgrade its GenoLogics Clarity LIMS. In scoping the requirements for this upgrade, Adaptive Biotechnologies realized that some enhancements, extensions, and interfaces (instruments and systems) were needed, and turned to CSols, a Clarity Certified Application Development (CCAD) partner, for assistance.
Adaptive engaged CSols to develop the enhancements, extensions, and interfaces, because of CSols’ expertise with Clarity LIMS, the Clarity LIMS API, and its laboratory and domain knowledge.
“CSols was fantastic to work with,” said Sean Nolan, chief technology officer of Adaptive Biotechnologies. “Their consultants were exactly what we needed.”
The project was completed successfully, on time and within budget. Consequently, Adaptive Biotechnologies was able to realize many benefits including:
- Increased usability, functionality, quality, and productivity by leveraging CSols Clarity LIMS API and domain expertise to facilitate the upgrade of GenoLogics Clarity LIMS
- Increased levels of automation and integration yielding greater efficiency and laboratory throughput
- Attained a high level of system adoption and utilization through the tailoring of functionality to fit Adaptive’s needs, without altering current work processes and methods
The full Project Case Study can be downloaded here.
About CSols, Inc.
CSols, Inc. is the premier Laboratory Informatics Consultancy, providing objective guidance and tailored solutions through their services: strategic planning and vendor selection, implementation and enhancement, and computer system validation. For more information, visit www.csolsinc.com.
About Adaptive Biotechnologies®
Adaptive Biotechnologies is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. Adaptive is bringing the accuracy and sensitivity of its immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. Adaptive also translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. For more information, visit adaptivebiotech.com.